Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nijsten

Showing results (241-250 of 701) with videos related to

Pageof 71
Sort By:
Medical Physics|March 6, 2004
Verification of treatment parameter transfer by means of electronic portal dosimetryS M J J G Nijsten, A W H Minken, P Lambin, et al.
Physics in Medicine and Biology|September 22, 2018
Should dose from small fields be limited for dose verification procedures?: uncertainty versus small field dose in VMAT treatmentsCecile J A Wolfs, Ans C C Swinnen, Sebastiaan M J J G Nijsten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Refractory hyperglycaemia induced by glucose-insulin-potassium infusion in acute myocardial infarctionM Vogelzang, T Svilaas, I C C van der Horst, et al.
Intensive Care Medicine|January 24, 2003
Irreversible ischemia of the hand after peripheral administration of tromethamol (THAM)Marjolijn N de Hooge, Bas H Verhoeven, Willem J M J Rutten, et al.
Clinical Rheumatology|June 15, 2016
Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)Eveline M Kool, Marieke J Nijsten, Annelies E van Ede, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2017
Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009R J T van der Leest, L M Hollestein, L Liu, et al.
Critical Care (London, England)|May 30, 2025
Cardiovascular effects of hypertonic lactate solutions: acid-base or metabolic cause, or both?Pedro J Freire Jorge, Rohan Boer, František Duška, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2018
Apathy and health-related quality of life in nursing home residentsJohanna M H Nijsten, Ruslan Leontjevas, Martin Smalbrugge, et al.
The British Journal of Dermatology|October 30, 2015
Dermatoepidemiology; what's up people?T Nijsten, C Apfelbacher, P Gisondi, et al.
Open Forum Infectious Diseases|March 3, 2022
Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic AreasSalma Oktaria, Fatih Anfasa, Sri Linuwih Menaldi, et al.
Pageof 71

Showing results (241-250 of 701) with videos related to

Sort By:
Pageof 71
Medical Physics|March 6, 2004
Verification of treatment parameter transfer by means of electronic portal dosimetryS M J J G Nijsten, A W H Minken, P Lambin, et al.
Physics in Medicine and Biology|September 22, 2018
Should dose from small fields be limited for dose verification procedures?: uncertainty versus small field dose in VMAT treatmentsCecile J A Wolfs, Ans C C Swinnen, Sebastiaan M J J G Nijsten, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Refractory hyperglycaemia induced by glucose-insulin-potassium infusion in acute myocardial infarctionM Vogelzang, T Svilaas, I C C van der Horst, et al.
Intensive Care Medicine|January 24, 2003
Irreversible ischemia of the hand after peripheral administration of tromethamol (THAM)Marjolijn N de Hooge, Bas H Verhoeven, Willem J M J Rutten, et al.
Clinical Rheumatology|June 15, 2016
Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)Eveline M Kool, Marieke J Nijsten, Annelies E van Ede, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2017
Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009R J T van der Leest, L M Hollestein, L Liu, et al.
Critical Care (London, England)|May 30, 2025
Cardiovascular effects of hypertonic lactate solutions: acid-base or metabolic cause, or both?Pedro J Freire Jorge, Rohan Boer, František Duška, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2018
Apathy and health-related quality of life in nursing home residentsJohanna M H Nijsten, Ruslan Leontjevas, Martin Smalbrugge, et al.
The British Journal of Dermatology|October 30, 2015
Dermatoepidemiology; what's up people?T Nijsten, C Apfelbacher, P Gisondi, et al.
Open Forum Infectious Diseases|March 3, 2022
Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic AreasSalma Oktaria, Fatih Anfasa, Sri Linuwih Menaldi, et al.
Pageof 71